(PhysOrg.com) -- For patients with gastrointestinal stromal tumors, or GISTs, the blockbuster cancer drug Gleevec has been a reason to hope. Since the drug’s introduction, survival rates have climbed ...

Medicine & Health - Cancer

Dec 23, 2010 4.7 / 5 (3) 0 |

Research by Michigan State University chemist Kevin Walker is paving the way for potentially cleaner, more efficient production of cancer-fighting paclitaxel -- better known as the blockbuster drug Taxol.

Chemistry - Biochemistry

Apr 02, 2009 5 / 5 (1) 0